Urethral cancer pathophysiology: Difference between revisions

Jump to navigation Jump to search
Line 7: Line 7:


==Microscopic Pathology==
==Microscopic Pathology==
* [[Female]]
* [[Female]]<ref name="pmid23608423">{{cite journal |vauthors=Cantiello F, Cicione A, Salonia A, Autorino R, Tucci L, Madeo I, Damiano R |title=Periurethral fibrosis secondary to prostatic inflammation causing lower urinary tract symptoms: a prospective cohort study |journal=Urology |volume=81 |issue=5 |pages=1018–23 |date=May 2013 |pmid=23608423 |doi=10.1016/j.urology.2013.01.053 |url=}}</ref>
:* The [[female]] [[urethra]] is lined by [[transitional cell]] [[mucosa]] proximally and [[stratified]] [[squamous]] cells distally. Therefore, [[transitional cell carcinoma]] is most common in the [[proximal]] [[urethra]] and [[Squamous cell carcinoma laboratory tests|squamous cell carcinoma]] predominates in the distal [[urethra]]. [[Adenocarcinoma]] may occur in both locations and arises from [[metaplasia]] of the numerous [[Periurethral phlegmon|periurethral]] [[glands]].
:* The [[female]] [[urethra]] is lined by [[transitional cell]] [[mucosa]] proximally and [[stratified]] [[squamous]] cells distally. Therefore, [[transitional cell carcinoma]] is most common in the [[proximal]] [[urethra]] and [[Squamous cell carcinoma laboratory tests|squamous cell carcinoma]] predominates in the distal [[urethra]]. [[Adenocarcinoma]] may occur in both locations and arises from [[metaplasia]] of the numerous [[Periurethral phlegmon|periurethral]] [[glands]].



Revision as of 19:48, 20 June 2018

Urethral cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Urethral cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT Scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Urethral cancer pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Urethral cancer pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Urethral cancer pathophysiology

CDC on Urethral cancer pathophysiology

Urethral cancer pathophysiology in the news

Blogs on Urethral cancer pathophysiology

Directions to Hospitals Treating Urethral cancer

Risk calculators and risk factors for Urethral cancer pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Vindhya BellamKonda, M.B.B.S [2]

Overview

The pathophysiology of urethral cancer depends on the histological subtypes.

Microscopic Pathology

References

  1. Cantiello F, Cicione A, Salonia A, Autorino R, Tucci L, Madeo I, Damiano R (May 2013). "Periurethral fibrosis secondary to prostatic inflammation causing lower urinary tract symptoms: a prospective cohort study". Urology. 81 (5): 1018–23. doi:10.1016/j.urology.2013.01.053. PMID 23608423.